News and Views
Nature Medicine 15, 363 - 364 (2009)
doi:10.1038/nm0409-363
Choosing between GVHD and delayed engraftment
Paul J Martin1
- Paul J. Martin is at the Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, Washington, USA. e-mail: pmartin@fhcrc.org
Abstract
Growth factors used to accelerate engraftment after hematopoietic cell transplantation can increase the severity of graft-versus-host disease. Experiments with mice examine how irradiation, used to prepare recipients for transplants, contributes to this problem (pages 436–441).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Portal Vein Tumor Thrombosis Revascularization During Sorafenib Treatment for Hepatocellular CarcinomaThe American Journal of Gastroenterology Letter
Induction of natural killer T cell?dependent alloreactivity by administration of granulocyte colony?stimulating factor after bone marrow transplantationNature Medicine Letter (01 Apr 2009)
See all 67 matches for Research
